• ROW-Products
    • US-Products
Novus Scientific ROW
  • Home
  • TIGR Matrix
    • Product information
    • Patient Information
    • Manufacturing
  • Evidence
    • Breast Reconstruction
      • Published
      • 3D film Pre-pectoral IBR
      • Brochure
    • AWR
      • Published
      • Posters
      • Cases
      • Procedure tips and tricks
      • Brochure
  • News & Events
  • Company Information
    • Contact Us
    • Sales Channels
    • Job Openings
    • About Us
Select Page

Virtual meeting 23rd of June

by editor | Jun 17, 2021 | Breast Reconstruction, Event, Novus Scientific

Save the date!
Paris, Wednesday 23rd of June

Dr Nicolas Leymarie & Dr Jean-Francois Honart

Plastic surgeons from the Gustave Roussy Institute share their
success story!

〉View PDF-file

Recent posts

  • Are patients most satisfied with a synthetic or a biological mesh in dual-plane immediate breast reconstruction after 5 years? A randomized controlled trial comparing the two meshes in the same patient 18 November, 2022
  • Comparing Complications of Biologic and Synthetic Mesh in Breast Reconstruction: A Systematic Review and Network Meta-Analysis 13 October, 2022
  • Mastectomy and Immediate Breast Reconstruction with Pre-Pectoral or Sub-Pectoral Implant: Assessing Clinical Practice, Post-Surgical Outcomes, Patient’s Satisfaction and Cost 2 October, 2022
  • Prophylactic onlay mesh at emergency laparotomy: promising early outcomes with long-acting synthetic resorbable mesh 1 July, 2022
  • A Retrospective Study Assessing the Outcomes of Immediate Prepectoral and Subpectoral Implant and Mesh-Based Breast Reconstruction 29 June, 2022
  • Press Release CE MDR TIGR Matrix 12 January, 2022
Copyright 2024 © Novus Scientific • Virdings Allé 2, 754 50 Uppsala, SWEDEN • TIGR® Matrix Surgical Mesh received 510(k) clearance by the FDA in 2010 and carries the CE-mark since 2011.
Vi använder cookies för att se till att vi ger dig den bästa upplevelsen på vår webbplats. Om du fortsätter att använda denna webbplats kommer vi att anta att du godkänner detta.Ok